Regulatory
Matters |
|
Benzocaine
Topical Products: Sprays, Gels and Liquids |
|
Bisphosphonates |
|
Buflomedil-containing
medicines |
|
Celecoxib |
|
Dolasetron
mesylate |
|
Ipilimumab |
|
Prasugrel |
|
Rosiglitazone |
|
Stavudine |
|
Tigecycline |
Safety of Medicines |
|
Drug-induced
hyponatraemia |
|
Immune
Globulin Subcutaneous (Human) |
|
Lenalidomide |
|
Long-Acting
Beta-Agonists (LABAs) |
|
Natalizumab |
|
Tumor
Necrosis Factor (TNF) blockers, azathioprine and/or mercaptopurine |
Feature |
|
Eighth
Meeting of the WHO Advisory Committee on Safety of Medicinal Products
(ACSoMP) |